Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Winer

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Leukemia & Lymphoma|May 10, 2015
Primary mediastinal large B-cell lymphoma in pregnancyStephen Fiascone, Ilina Datkhaeva, Eric S Winer, et al.
Oncology (Williston Park, N.Y.)|June 7, 2005
GM-CSF and low-dose cytosine arabinoside in high-risk, elderly patients with AML or MDSEric S Winer, Kenneth B Miller, Geoffrey W Chan
American Journal of Hematology|November 26, 2013
Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Leukemia Research|May 20, 2014
Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphomaAdam J Olszewski, Eric S Winer, Jorge J Castillo
Cancer Causes & Control : CCC|June 10, 2015
Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data BaseAdam J Olszewski, Eric S Winer, Jorge J Castillo
Cancer|August 6, 2013
Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Expert Opinion on Investigational Drugs|February 4, 2012
PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignanciesEric S Winer, Randall R Ingham, Jorge J Castillo
Medicine and Health, Rhode Island|January 11, 2011
Alphabet soup: RAEB, HMA, DOE, and AFOPNathan T Connell, Heather M Cassidy, David Berz, et al.
American Journal of Hematology|January 3, 2014
Primary refractory Hodgkin lymphoma: limited options and poor survival--but not alwaysAruna Gavini, John L Reagan, Eric S Winer, et al.
British Journal of Haematology|January 24, 2015
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphomaJorge J Castillo, John L Reagan, William M Sikov, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|May 10, 2015
Primary mediastinal large B-cell lymphoma in pregnancyStephen Fiascone, Ilina Datkhaeva, Eric S Winer, et al.
Oncology (Williston Park, N.Y.)|June 7, 2005
GM-CSF and low-dose cytosine arabinoside in high-risk, elderly patients with AML or MDSEric S Winer, Kenneth B Miller, Geoffrey W Chan
American Journal of Hematology|November 26, 2013
Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Leukemia Research|May 20, 2014
Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphomaAdam J Olszewski, Eric S Winer, Jorge J Castillo
Cancer Causes & Control : CCC|June 10, 2015
Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data BaseAdam J Olszewski, Eric S Winer, Jorge J Castillo
Cancer|August 6, 2013
Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Expert Opinion on Investigational Drugs|February 4, 2012
PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignanciesEric S Winer, Randall R Ingham, Jorge J Castillo
Medicine and Health, Rhode Island|January 11, 2011
Alphabet soup: RAEB, HMA, DOE, and AFOPNathan T Connell, Heather M Cassidy, David Berz, et al.
American Journal of Hematology|January 3, 2014
Primary refractory Hodgkin lymphoma: limited options and poor survival--but not alwaysAruna Gavini, John L Reagan, Eric S Winer, et al.
British Journal of Haematology|January 24, 2015
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphomaJorge J Castillo, John L Reagan, William M Sikov, et al.
Pageof 8